RAB1B and non-small cell lung carcinoma: In 2020, Deng et al. 29 discovered that miR-135a can inhibit NSCLC cell replication, invasion, and spread through down-regulation of RAB1B and the RAS pathway, effectively suppressing the progression and spread of NSCLC.